PT2748147T - 2-alquilo-1-oxo-n-fenilo-3-heteroarilo-1,2,3,4 tetrahidroisoquinolina-4-carboxamidas substituídas para terapias antimaláricas - Google Patents

2-alquilo-1-oxo-n-fenilo-3-heteroarilo-1,2,3,4 tetrahidroisoquinolina-4-carboxamidas substituídas para terapias antimaláricas

Info

Publication number
PT2748147T
PT2748147T PT127724706T PT12772470T PT2748147T PT 2748147 T PT2748147 T PT 2748147T PT 127724706 T PT127724706 T PT 127724706T PT 12772470 T PT12772470 T PT 12772470T PT 2748147 T PT2748147 T PT 2748147T
Authority
PT
Portugal
Prior art keywords
tetrahydroisoquinoline
carboxamides
heteroaryl
oxo
phenyl
Prior art date
Application number
PT127724706T
Other languages
English (en)
Inventor
Kiplin Guy Rodney
Zhu Fangyi
Armand Guiguemde Wendyam
Floyd David
Knapp Spencer
Stein Philip
Castro Steve
Original Assignee
Medicines For Malaria Venture Mmv
St Jude Children's Res Hospital
Univ Rutgers
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medicines For Malaria Venture Mmv, St Jude Children's Res Hospital, Univ Rutgers filed Critical Medicines For Malaria Venture Mmv
Publication of PT2748147T publication Critical patent/PT2748147T/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/472Non-condensed isoquinolines, e.g. papaverine
    • A61K31/4725Non-condensed isoquinolines, e.g. papaverine containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06Antimalarials
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PT127724706T 2011-08-25 2012-08-24 2-alquilo-1-oxo-n-fenilo-3-heteroarilo-1,2,3,4 tetrahidroisoquinolina-4-carboxamidas substituídas para terapias antimaláricas PT2748147T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201161527594P 2011-08-25 2011-08-25

Publications (1)

Publication Number Publication Date
PT2748147T true PT2748147T (pt) 2017-11-14

Family

ID=47018313

Family Applications (1)

Application Number Title Priority Date Filing Date
PT127724706T PT2748147T (pt) 2011-08-25 2012-08-24 2-alquilo-1-oxo-n-fenilo-3-heteroarilo-1,2,3,4 tetrahidroisoquinolina-4-carboxamidas substituídas para terapias antimaláricas

Country Status (19)

Country Link
US (1) US9416124B2 (pt)
EP (1) EP2748147B1 (pt)
JP (1) JP6035334B2 (pt)
CN (1) CN103930404B (pt)
BR (1) BR112014004437B1 (pt)
CA (1) CA2846507C (pt)
CY (1) CY1119748T1 (pt)
DK (1) DK2748147T3 (pt)
ES (1) ES2644082T3 (pt)
HK (1) HK1199443A1 (pt)
HR (1) HRP20171567T1 (pt)
HU (1) HUE034721T2 (pt)
LT (1) LT2748147T (pt)
ME (1) ME02908B (pt)
PL (1) PL2748147T3 (pt)
PT (1) PT2748147T (pt)
RS (1) RS56544B1 (pt)
SI (1) SI2748147T1 (pt)
WO (1) WO2013027196A1 (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3672597A4 (en) * 2017-08-21 2021-09-22 Navigen, Inc. ARF6 INHIBITORS AND RELATED PROCEDURES
EP3892332A1 (en) 2020-04-09 2021-10-13 University Of Kentucky Research Foundation New anti-malarial agents
AU2022258682A1 (en) 2021-04-15 2023-10-12 Pags Co., Ltd. Isoquinoline derivatives for use as antiviral and antitumour agents
EP4074314A1 (en) 2021-04-15 2022-10-19 Valdospan GmbH Isoquinoline derivatives for use as antiviral and antitumour agents
WO2024083802A1 (en) 2022-10-17 2024-04-25 Valdospan Gmbh Isoquinoline derivatives as protein degraders, e7 degraders, antivirals, tumor therapeutics and immune suppressives

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5409938A (en) * 1994-02-14 1995-04-25 The United States Of America As Represented By The Secretary, Department Of Health And Human Services Antimalarial korupensamines and pharmaceutical compositions and medical uses thereof
US5639761A (en) 1994-02-14 1997-06-17 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Antimalarial naphthylisoquinoline alkaloids and pharmaceutical compositions and medical uses thereof
US6921762B2 (en) * 2001-11-16 2005-07-26 Amgen Inc. Substituted indolizine-like compounds and methods of use
WO2004004727A1 (en) 2002-07-03 2004-01-15 Axys Pharmaceuticals, Inc. 3,4-dihydroisoquinolin-1-one derivatives as inducers of apoptosis
DE10237722A1 (de) * 2002-08-17 2004-08-19 Aventis Pharma Deutschland Gmbh Indol- oder Benzimidazolderivate zur Modulation der IKappaB-Kinase
DE10312963A1 (de) * 2003-03-24 2004-10-07 Aventis Pharma Deutschland Gmbh Substituierte 4-Phenyltetrahydroisochinoline, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament, sowie sie enthaltendes Medikament
AR053346A1 (es) * 2005-03-25 2007-05-02 Glaxo Group Ltd Compuesto derivado de 8h -pirido (2,3-d) pirimidin -7 ona 2,4,8- trisustituida composicion farmaceutica y uso para preparar una composicion para tratamiento y profilxis de una enfermedad mediada por la quinasa csbp/ rk/p38
RU2302417C1 (ru) 2006-03-14 2007-07-10 Иващенко Андрей Александрович 1-оксо-3-(1н-индол-3-ил)-1,2,3,4-тетрагидроизохинолины, способы их получения, комбинаторная библиотека и фокусированная библиотека
RU2010151605A (ru) * 2008-05-19 2012-06-27 Актелион Фармасьютиклз Лтд (Ch) Новые тетрагидроизохинолины в качестве антималярийных агентов
GB0820856D0 (en) * 2008-11-14 2008-12-24 Univ Leuven Kath Novel inhibitors of flavivirus replication

Also Published As

Publication number Publication date
SI2748147T1 (sl) 2017-11-30
HUE034721T2 (hu) 2018-02-28
HRP20171567T1 (hr) 2017-11-17
EP2748147B1 (en) 2017-08-02
HK1199443A1 (en) 2015-07-03
WO2013027196A1 (en) 2013-02-28
EP2748147A1 (en) 2014-07-02
LT2748147T (lt) 2017-10-25
JP6035334B2 (ja) 2016-11-30
BR112014004437A8 (pt) 2018-01-23
JP2014524464A (ja) 2014-09-22
BR112014004437B1 (pt) 2021-12-14
BR112014004437A2 (pt) 2017-03-28
ME02908B (me) 2018-10-20
US20140235593A1 (en) 2014-08-21
WO2013027196A9 (en) 2013-04-18
DK2748147T3 (da) 2017-11-13
CA2846507A1 (en) 2013-02-28
CN103930404B (zh) 2016-08-24
CN103930404A (zh) 2014-07-16
ES2644082T3 (es) 2017-11-27
CA2846507C (en) 2020-03-10
CY1119748T1 (el) 2018-06-27
RS56544B1 (sr) 2018-02-28
US9416124B2 (en) 2016-08-16
PL2748147T3 (pl) 2018-01-31

Similar Documents

Publication Publication Date Title
EP2875029B8 (en) 5,5-heteroaromatic anti-infective compounds
EP2688642A4 (en) neurostimulator
EP2762476A4 (en) 1,2,4-triazine-6-carboxamide derivative
PL2551190T3 (pl) Zmiennopłat
PL2551198T3 (pl) Zmiennopłat
EP2935214A4 (en) 1,4-PYRIDONES COMPOUNDS
GB201112931D0 (en) Metail 3
GB201216143D0 (en) .
EP2699091A4 (en) 2 ', 6'-dioxo-3'-deutero-PIPERIDIN-3-YL-isoindoline COMPOUNDS
GB201203412D0 (en) .
HK1192757A1 (zh) 取代的 -芳基- -苯基- -三嗪- -胺
HK1207317A1 (en) Substituted 1,6-naphthyridines 16-
GB201112922D0 (en) Micro-organ
HK1199443A1 (en) Substituted 2-alkyl-1-oxo-n-phenyl-3-heteroaryl-1,2,3,4-tetrahyd roisoquinoline-4-carboxamides for antimalarial therapies 2--1--n--3--1,2,3,4- -4-
GB201203063D0 (en) .
GB201115344D0 (en) The FitCase
HK1191942A1 (zh) 新型六氫環戊二烯並吡咯酮,六氫吡咯並吡咯酮,八氫吡咯並吡啶酮和八氫吡啶酮化合物
GB201112721D0 (en) Antimalarial
GB201115921D0 (en) The Denness fast-loo
GB201203786D0 (en) .
GB201204535D0 (en) .
GB201204735D0 (en) The quadtrolley
GB201120548D0 (en) .
GB201120676D0 (en) The degravitator
GB201113021D0 (en) .